Mutation type is not clinically useful in predicting prognosis in hypertrophic cardiomyopathy.

dc.contributor.author

Landstrom, AP

dc.contributor.author

Ackerman, MJ

dc.date.accessioned

2020-04-01T13:45:54Z

dc.date.available

2020-04-01T13:45:54Z

dc.date.issued

2010-12

dc.date.updated

2020-04-01T13:45:53Z

dc.identifier

122/23/2441

dc.identifier.issn

0009-7322

dc.identifier.issn

1524-4539

dc.identifier.uri

https://hdl.handle.net/10161/20332

dc.language

eng

dc.publisher

Ovid Technologies (Wolters Kluwer Health)

dc.relation.ispartof

Circulation

dc.relation.isversionof

10.1161/CIRCULATIONAHA.110.954446

dc.subject

Humans

dc.subject

Cardiomyopathy, Hypertrophic

dc.subject

Prognosis

dc.subject

Predictive Value of Tests

dc.subject

Genotype

dc.subject

Mutation

dc.title

Mutation type is not clinically useful in predicting prognosis in hypertrophic cardiomyopathy.

dc.type

Journal article

duke.contributor.orcid

Landstrom, AP|0000-0002-1878-9631

pubs.begin-page

2441

pubs.end-page

2450

pubs.issue

23

pubs.organisational-group

School of Medicine

pubs.organisational-group

Cell Biology

pubs.organisational-group

Pediatrics, Cardiology

pubs.organisational-group

Duke

pubs.organisational-group

Basic Science Departments

pubs.organisational-group

Pediatrics

pubs.organisational-group

Clinical Science Departments

pubs.publication-status

Published

pubs.volume

122

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Review - Mutation Prognosis in HCM.pdf
Size:
902.34 KB
Format:
Adobe Portable Document Format